Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Made Scientific Establishes Princeton, New Jersey, Manufacturing-Headquarters Operations

08/18/2025
Made Scientific, a cell therapy contract development and manufacturing organization, has established operations in Princeton, New Jersey. The $12 million project is expected to create more than 100 jobs.

The company’s new 60,000-square-foot GMP manufacturing facility and headquarters features five (5) ISO 7 / Grade B cleanrooms, in-house quality control labs, and dedicated process and analytical development capabilities.

"Today is more than a ribbon cutting. It is a clear signal of our commitment to this incredible industry and to this region," said Syed T. Husain, Chairman and CEO of Made Scientific. "This facility is a testament to our dedication to supporting the next generation of cell therapy innovators for clinical-to-commercial manufacturing, all under one roof. With a globally compliant infrastructure, high-throughput GMP capacity, and a world-class team built for precision and speed, we are here to help our partners bring transformative therapies to patients with confidence and efficiency."

Made Scientific specializes in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials. The company provides a range of services, including process and analytical development, GMP manufacturing, and quality control testing.

"Made Scientific's investment in Plainsboro Township is a testament to how New Jersey continues to lead the nation in life sciences and advanced biomanufacturing," noted Governor Phil Murphy. "Investing in this new facility creates good-paying, high-quality jobs for New Jerseyans. We are proud of companies like Made Scientific that are fueling the advancement of life-saving therapies and driving our innovation economy forward."

Exclusive Research